XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Supplemental Balance Sheet Information
6 Months Ended
Jun. 30, 2022
Supplemental Balance Sheet Information [Abstract]  
Supplemental Balance Sheet Information

Note 4. Supplemental balance sheet information

Property and equipment

Property and equipment, net consisted of the following:

 

(in thousands)

 

June 30,
2022

 

 

December 31,
2021

 

Scientific equipment

 

$

3,027

 

 

$

2,970

 

Furniture & office equipment

 

 

1,226

 

 

 

1,002

 

Leasehold improvements

 

 

1,039

 

 

 

1,071

 

Total

 

 

5,292

 

 

 

5,043

 

Accumulated depreciation and amortization

 

 

(3,021

)

 

 

(2,971

)

Property & equipment, net

 

$

2,271

 

 

$

2,072

 

 

Depreciation and amortization expense was $0.2 million for the three months ended June 30, 2022 and 2021, respectively, and $0.4 and $0.3 million for the six months ended June 30, 2022 and 2021, respectively,

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following:

 

(in thousands)

 

June 30,
2022

 

 

December 31,
2021

 

Accrued clinical trial costs

 

$

10,963

 

 

$

12,991

 

Accrued personnel costs

 

 

2,723

 

 

 

3,884

 

Accrued professional fees

 

 

27

 

 

 

25

 

Accrued other

 

 

93

 

 

 

257

 

Total accrued expenses and other current liabilities

 

$

13,806

 

 

$

17,157